Global Homoharringtonine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Homoharringtonine Market Research Report 2024
Homoharringtonine is an alkaloid obtained from the Tricuspidaceae plant, Tritaxus, or plants of the same genus. It has an inhibitory effect on the incorporation of 3H-labeled asparagine into proteins, and it also has an effect on the incorporation of 3H-labeled thymidine into DNA. Homoharringtonine can also induce cell differentiation, increase the content of cAMP, and inhibit glycoprotein synthesis. Under the electron microscope, it can be seen that the chromatin concentrates and condenses toward the edge of the nucleus, forms chromosome clumps and bulges out of the nucleus, develops into "litter bodies" where the nucleus separates, and finally the nucleus fragments. After intravenous injection of 3H-labeled homoharringtonine to rats, 15 minutes later the radioactivity was distributed in the kidney, liver, bone marrow, heart, and gastrointestinal tract.
According to Mr Accuracy reports’s new survey, global Homoharringtonine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Homoharringtonine market research.
For the treatment of acute myeloid leukemia, combined with VCR, Ara-C, and prednisone, can improve the curative effect. It also has a certain effect on acute monocytic leukemia and malignant lymphoma. It can also be used for polycythemia vera, chronic myelogenous leukemia and promyelocytic leukemia.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Homoharringtonine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
TaiHua
JiZhi
Rhawn
Dao SiFu
J&K
Yi Tai
TaiTan
HanHong
XiLi
Pu RuiFa
RongHe
Bidel
Target Mol
JingcuiTianCheng
SIGMA-RBI
Alexis Corporation
CHEMICAL LAND21
Discovery Fine Chemicals
kemikalieimport
Toronto Research Chemicals
GLR Innovations
Glentham Life Sciences
Cayman Chemical Company
ChemScene
JR MediChem
Crysdot
Segment by Type
98% Purity
99% Purity
Medical
Biochemical Research
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Homoharringtonine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Homoharringtonine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Homoharringtonine market research.
For the treatment of acute myeloid leukemia, combined with VCR, Ara-C, and prednisone, can improve the curative effect. It also has a certain effect on acute monocytic leukemia and malignant lymphoma. It can also be used for polycythemia vera, chronic myelogenous leukemia and promyelocytic leukemia.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Homoharringtonine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
TaiHua
JiZhi
Rhawn
Dao SiFu
J&K
Yi Tai
TaiTan
HanHong
XiLi
Pu RuiFa
RongHe
Bidel
Target Mol
JingcuiTianCheng
SIGMA-RBI
Alexis Corporation
CHEMICAL LAND21
Discovery Fine Chemicals
kemikalieimport
Toronto Research Chemicals
GLR Innovations
Glentham Life Sciences
Cayman Chemical Company
ChemScene
JR MediChem
Crysdot
Segment by Type
98% Purity
99% Purity
Segment by Application
Medical
Biochemical Research
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Homoharringtonine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source